Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 74
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04681079 | Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19 | ||
| NCT02820311 | Thorough QT (TQT) Study of TD-4208 in Healthy Subjects | ||
| NCT02657122 | SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects | ||
| NCT01321879 | Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients | ||
| NCT02392208 | Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5 | ||
| NCT01040637 | A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation | ||
| NCT01644240 | A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects | ||
| NCT00550225 | Succinate Salt Version of GSK961081 for Healthy Volunteers | ||
| NCT01718938 | Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis | ||
| NCT02116543 | TD-6450 MAD Study in HCV Infected Subjects | ||
| NCT02581592 | Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment | ||
| NCT02040792 | A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT03829657 | Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT03573817 | A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD | ||
| NCT04200573 | Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855 | ||
| NCT02022306 | TD-6450 SAD and MAD in Healthy Subjects | ||
| NCT04589260 | TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT04688632 | Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects | ||
| NCT01458340 | A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
| NCT01459926 | A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation | ||
| NCT02518139 | A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT01568411 | A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211 | ||
| NCT02109172 | A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT03750565 | Multiple Dose Ethnobridging PK Study in Healthy Subjects | ||
| NCT03103412 | TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC) | ||
| NCT01791049 | TD-1607 SAD Study in Healthy Subjects | ||
| NCT02512510 | Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT05696717 | Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy | ||
| NCT04402866 | TD-0903 for ALI Associated With COVID-19 | ||
| NCT00887406 | Study of GSK961081 in Healthy Volunteer Subjects | ||
| NCT02772159 | TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | ||
| NCT03432793 | Drug-Drug Interaction (DDI) Study for TD-9855 | ||
| NCT01924143 | TD-9855 Mass Balance Study | ||
| NCT02954263 | Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects | ||
| NCT02663089 | A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | ||
| NCT01704404 | 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease | ||
| NCT03095456 | Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD | ||
| NCT02639078 | Single Ascending Dose Study of TD-0714 in Healthy Subjects | ||
| NCT04587713 | Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects | ||
| NCT02903095 | Single Ascending Dose Study of TD-1439 in Healthy Subjects | ||
| NCT04315558 | Revefenacin in Acute Respiratory Insufficiency in COPD | ||
| NCT03750552 | Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT02753855 | Pharmacokinetics of Telavancin in Normal and Obese Subjects | ||
| NCT03920254 | TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study | ||
| NCT03408470 | TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects | ||
| NCT03652038 | Single and Multiple Ascending Dose Study of TD-8236 by Inhalation | ||
| NCT04095793 | Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure | ||
| NCT01949103 | TD-1607 MAD Study in Healthy Subjects | ||
| NCT00687700 | A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers | ||
| NCT04150341 | Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response |
